Import Authorization

Workflow steps

1. Import Intent
   Norway is an import-only country with no domestic commercial cannabis production. All medicinal cannabis must be imported under NoMA authorization.
   • Specialist physician prescription
   • Section 4-4 authorization for unlicensed medicine
   • EU-GMP Part I certificate mandatory
2. Specialist Physician Application
   Prescribing specialist applies to NoMA for named-patient import authorization (Section 4-4). Must document treatment failure of conventional therapies.
   • Specialist qualification documentation
   • Documented treatment failure of conventional therapies
   • Product identification (name, manufacturer, THC/CBD content)
   • Patient clinical justification
3. NoMA Import Authorization
   NoMA issues per-patient, per-product import authorization. Processing: approximately 4–6 weeks. Authorization specifies product, quantity, and duration.
   • NoMA Section 4-4 authorization
   • Product-specific — not blanket
   • Authorization linked to named patient
   • EU-GMP Part I certificate from manufacturer
4. Authorization granted?
   NoMA reviews clinical justification. Conservative approach — may request additional documentation.
5. Import Authorized ✓
   Product may be imported for the named patient. Dispensed via hospital pharmacy.